Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VASOPRESSIN Cause Obstructive airways disorder? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Obstructive airways disorder have been filed in association with VASOPRESSIN (Vasopressin). This represents 0.4% of all adverse event reports for VASOPRESSIN.

7
Reports of Obstructive airways disorder with VASOPRESSIN
0.4%
of all VASOPRESSIN reports
7
Deaths
7
Hospitalizations

How Dangerous Is Obstructive airways disorder From VASOPRESSIN?

Of the 7 reports, 7 (100.0%) resulted in death, 7 (100.0%) required hospitalization, and 7 (100.0%) were considered life-threatening.

Is Obstructive airways disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VASOPRESSIN. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does VASOPRESSIN Cause?

Drug ineffective (1,018) Off label use (312) Cardiogenic shock (305) Multiple organ dysfunction syndrome (277) Condition aggravated (251) Hypotension (241) Hyponatraemia (235) Vomiting (233) Sepsis (230) Abdominal pain (221)

What Other Drugs Cause Obstructive airways disorder?

ALBUTEROL (4,195) TIOTROPIUM (2,634) PREDNISONE (2,480) BUDESONIDE\FORMOTEROL (2,210) MONTELUKAST (2,073) MEPOLIZUMAB (1,883) OMALIZUMAB (1,670) CICLESONIDE (1,403) FLUTICASONE\SALMETEROL (1,253) BUDESONIDE (1,214)

Which VASOPRESSIN Alternatives Have Lower Obstructive airways disorder Risk?

VASOPRESSIN vs VECTIBIX VASOPRESSIN vs VECURONIUM VASOPRESSIN vs VEDOLIZUMAB VASOPRESSIN vs VELAGLUCERASE ALFA VASOPRESSIN vs VELCADE

Related Pages

VASOPRESSIN Full Profile All Obstructive airways disorder Reports All Drugs Causing Obstructive airways disorder VASOPRESSIN Demographics